Page 39 - Sequencing News Today

- Leaders in biotech and genomics to launch more personalised genomic solutions to more than 10,000 people across the Baltics and Mediterranean regions -L'AQUILA, Italy, Nov. 01, 2022, a global leader

In this application note, Honeycomb shows how to reduce your scRNAseq sequencing costs. 

GUANGZHOU, China, Oct. 25, 2022 -- Burning Rock Biotech Limited , a company focused on the application of next generation sequencing technology in the field of precision oncology, today announced... | October 25, 2022

BRISBANE, Australia, Oct. 20, 2022 /PRNewswire/ -- BGI Australia's lab has achieved accreditation from the National Association of Testing Authorities (NATA) to perform clinical Whole Exome

Markets, — went into trying to explain to the markets, trying to explain to the british— markets, trying to explain to the british public why they were pressing ahead with the radical progrowth agenda, why they were doing _ progrowth agenda, why they were doing it _ progrowth agenda, why they were doing it at — progrowth agenda, why they were doing it at a time when the economic headwinds _ doing it at a time when the economic headwinds were so powerfully against us, and _ headwinds were s...

Svante Pääbo has won the Nobel Prize for medicine for “his discoveries concerning the genomes of extinct hominins and human evolution,” it has been announced.

Theyve chosen to obstruct instead of work in a bipartisan way to achieve something theyve long claimed they wanted to do. senator manchin, myself and others will continue to have conversation bs the best way to ensure responsible permitting reforms passed before the end of the year. paul: were back our panel dan and kim strassel and kyle peterson so kyle i think joe manchin had thought he get the votes of enough republicans to break a filibuster but he didnt. why did republicans oppose this in t...

Protect your RNA from degradation AMSBIO announce RNAdvantage - the first product in a new range of stabilisation solutions that provide robust protection for your RNA samples at ambient temperature. Click to read more...

Initial development and validation of clinical trial assay Next-generation sequencing (NGS) based assay targeting LRRK2 from blood samples Collaboration expands QIAGEN's NGS testing

Extensive Curation of Asian-Specific Genetic Variants Enables Identification of Individuals at Elevated Risk of a Heart Attack